Background: Organ transplant recipients are vulnerable to multiple infectious agents and in
a world with a circulating SARS-CoV-2 virus, it would be expected that patients who are …

Objectives The novel 2019 coronavirus (COVID-19) was first described in December 2019 in
Wuhan, China and subsequently announced as a pandemic on March 12, 2020. In several …

Background. Coronavirus disease-19 (COVID-19) is associated with significant mortality.
The elderly, patients with comorbidities, and solid organ transplant (SOT) recipients are …

We report the nationwide experience with solid organ transplant (SOT) and hematopoietic
stem cell transplant (HSCT) recipients diagnosed with coronavirus disease 2019 (COVID …

Background. The risk of COVID-19 infection in transplant recipients (TRs) is unknown.
Patients on dialysis may be exposed to greater risk of infection due to an inability to isolate …

Background. Solid organ transplant (SOT) recipients are considered to be “vulnerable” to
COVID-19 infection due to immunosuppression. To date, there are no studies that compared …

Solid organ transplant recipients may be at a high risk for SARS‐CoV‐2 infection and poor
associated outcomes. We herein report our initial experience with solid organ transplant …

Background. There is a scarcity of data on the consequences of coronavirus disease-19
(COVID-19) infections in kidney transplant recipients (KTRs) from emerging countries …

Coronavirus disease (COVID-19) rapidly progresses to severe acute respiratory syndrome.
This review aimed at collating available data on COVID-19 infection in solid organ …

Background. In this study, we report the epidemiology of COVID-19 among recipients of
organ transplantation and evaluate associated factors with death. Methods. We screened …